MedPath

Acyclovir

PRESCRIBING INFORMATION Acyclovir Capsules USP

Approved
Approval ID

37499620-6a17-40f1-b0db-dd79320ea21d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 6, 2017

Manufacturers
FDA

Carlsbad Technology, Inc.

DUNS: 781047246

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acyclovir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61442-114
Application NumberANDA206261
Product Classification
M
Marketing Category
C73584
G
Generic Name
Acyclovir
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 6, 2017
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ACYCLOVIRActive
Quantity: 200 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acyclovir - FDA Drug Approval Details